The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
Early detection and treatment of tuberculosis crucial to prevent spread, with emphasis on proper diagnosis, medication, and diet.
India accounts for 26% of the world’s TB burden and 27% of global multi-drug resistant tuberculosis, which underscore the ...
Wang Jianwei, director general of the Chinese Center for Disease Control and Prevention, said that in China the number of new ...
Taking steps towards eradicating tuberculosis (TB), the Government of India has launched the 100-Day TB Mukt Bharat Abhiyan ...
Pain in your belly or around the pelvic region is also among the possible symptoms if TB has spread, while at the other end ...
Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.
21h
AllAfrica on MSNExcitement Builds for Long-Acting TB Treatments, but Research Still At Early StageBoth TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working on new long-acting formulations that might, for example, reduce an entire ...
The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results